In 2014, OBI Pharma established the “Corporate Social Responsibility Practice Code” as a governance regulation to ensure internal adherence to environmental and social sustainability commitments and fulfill the information disclosure obligations of a publicly listed company. This code has been continuously updated to reflect changes in government regulations and the company’s evolving needs. In 2021, it was revised to the “Sustainability Development Practice Code,” which was approved and implemented by the Board of Directors.
According to this code, sustainability matters are overseen by the Board of Directors, with the establishment of a Sustainability Execution Committee led by the CEO as the Chair. The committee is supported by an Executive Secretariat managed by the Public Affairs Department. The sustainability matters are categorized into five project teams: Corporate Governance and Economics, Product Services, Employee Care, Social Responsibility, and Environmental Sustainability. Each team is composed of representatives from relevant departments. Through internal meetings, the teams promote the concept of corporate sustainability, identify and analyze sustainability topics, and disclose the results of stakeholder consultations and sustainability achievements in the annually published sustainability report, which is also presented to the Board of Directors.
